Leadership1 publisher3 min readPublished
Death Clock founder Brent Franson calls his four years on a liked app 'slow failure'
Brent Franson spent four years on Most Days, a mental-health app users liked but that could not win them cheaply, before shutting it in late 2024. His test for stopping rests on founder conviction, though the flaw he names, costly user acquisition, was measurable.
The Board Room · Leadership desk
What happened
- Franson's team discarded the Most Days codebase and carried none of it into Death Clock, a health app that estimates a user's likely age of death.
- Most Days' investors were given a choice between taking back a fraction of their investment and backing the Death Clock idea.
- The team weighed calling the new product More Years before keeping Death Clock, the provocative working name it had used internally.
- Death Clock does not sell peptides because its clinical advisors doubt the science, a choice Franson said gives up potential revenue.
Compiled by The Board RoomSomething wrong?How this is made
Why it matters
- cost Slow failure is paid for from investor capital: each extra year of iteration shrinks what backers can recover, and Most Days' investors were left weighing a partial return against an untested idea.
- decision Teams iterating on a well-liked product this quarter face the choice Franson faced late: fix a cost threshold and review date now, or rely on spotting their own rationalization later.
- exposure Death Clock's reliance on a memorable name to avoid paid acquisition leaves it open to users who will not take a product with that name seriously as health advice, a risk Franson acknowledges.
The dangerous case, in Franson's account, is the middle one. He said the scary part of pivoting comes when users like a product and it has just enough promise to make another round of changes seem worthwhile [6]. He described the trap as a product that seemed "pretty good" but was not viable [22]. "You can convince yourself to keep iterating on it," he said [7].
Experience did not protect him from it. Franson, 44, had sold a previous software company to WeWork in 2019 [21], and he still spent four years on Most Days [1]. He calls the pattern "slow failure," a business that lingers because its leaders keep rationalizing why it might soon work [8]. "Mediocrity is so dangerous," he said [17].
His test for catching it is a judgement about state of mind: whether founders are working through concrete problems with conviction or trying to talk themselves into continuing [9]. In my view the test is honest. Its weakness is that it asks the people doing the rationalizing to notice it in themselves. The flaw Franson named in Most Days was economic, and a finance team can track it. The app had users but could not acquire them cheaply enough to build a sound business, he said [5]. The article does not give Most Days' acquisition costs or what a user was worth, so there is no way to say when a cost threshold would have tripped.
The board-deck version of a product like Most Days is a slide of engaged users and a plan for the next release. It is incomplete because the thing that sank Most Days, by Franson's account, was the cost of acquiring each of those users [5]. A kill criterion written before the next round, pairing acquisition cost against revenue per user and fixing a review date, would turn the conviction test into a line the team set before it saw the results.
A founder would object that a hard line also kills slow successes. Franson concedes the difficulty. "It's hard to tell the difference, a lot of times, between slow success and slow failure," he said [18]. His lesson from Most Days was not that founders should never persist, but that they should recognize when persistence has become rationalization [19]. A threshold set in advance does not answer that question for them. It fixes the date on which they have to answer it, with the cost figures in front of them.
The clean break closed off the half-measures. Franson ruled out a rebrand or a savvy hire and shut Most Days down completely [10]. The next question is whether Death Clock can reach customers without paying heavily for them. Franson said Most Days taught him that product quality alone would not carry a consumer company; it also needs a way to get attention without spending heavily to buy it [20]. He now cites the idea that first-time founders focus on product and second-time founders on distribution [15]. He treats the Death Clock name as that distribution in a crowded market where well-funded rivals can spend heavily on acquisition [14]. "People either loved the name Death Clock, or they hated it, but they didn't forget it," he said [13].
What to watch
- Whether Death Clock reports user growth or acquisition costs showing the name works as a low-cost channel.
- Whether Death Clock keeps its refusal to sell peptides if revenue falls short of plan.
- Whether Franson describes a stated threshold for Death Clock, given his own test for slow failure.